Chemoinformaics analysis of (1,7,7-TRIMETHYL-2-BICYCLO[2.2.1]HEPTANYL) 2-METHYLBUTANOATE
| Molecular Weight | 238.371 | nRot | 3 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 0 |
| Exact Molecular Weight | 238.193 | nRing | 2 |
| Solubility: LogS | -7.397 | nHRing | 0 |
| Solubility: LogP | 9.767 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.252 |
| Synth | 1.681 |
| Natural Product Likeliness | 0.488 |
| NR-PPAR-gamma | 0.028 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.806 |
| MDCK | 0.00000642 |
| BBB | 0.043 |
| PPB | 0.981234 |
| VDSS | 4.239 |
| FU | 0.0136011 |
| CYP1A2-inh | 0.116 |
| CYP1A2-sub | 0.173 |
| CYP2c19-inh | 0.266 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.959 |
| CYP2d6-inh | 0.129 |
| CYP2d6-sub | 0.025 |
| CYP3a4-inh | 0.197 |
| CYP3a4-sub | 0.045 |
| CL | 4.871 |
| T12 | 0.028 |
| hERG | 0.254 |
| Ames | 0.005 |
| ROA | 0.021 |
| SkinSen | 0.955 |
| Carcinogencity | 0.027 |
| EI | 0.936 |
| Respiratory | 0.236 |
| NR-Aromatase | 0.035 |
| Antiviral | Yes |
| Prediction | 0.870445 |